prikaz prve stranice dokumenta Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
  Preuzmi
PDF 2.84 MB
Znanstveni rad - Poglavlje u knjizi
Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
U: Updates on Renal Replacement Therapy / H.L. Wu, Henry (ur.). IntechOpen, 2024. str. 1-33. https://doi.org/10.5772/intechopen.114022
Vujičić, Božidar; Benko, Koraljka; Petretić, Ana; Nemarnik, Nenad; Spicijarić, Matko; Markić, Dean; Bura, Matej; Kadum, Fabio; Rački, Sanjin; Ružić, Alen

Citirajte ovaj rad

Vujičić, B., Benko, K., Petretić, A., Nemarnik, N., Spicijarić, M., Markić, D. ... Ružić, A. (2024). Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease. U H. H.L. Wu, (Ur.), Updates on Renal Replacement Therapy (str. 1-33). IntechOpen. doi: 10.5772/intechopen.114022

Vujičić, Božidar, et al. "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease." Updates on Renal Replacement Therapy, Ur. Henry H.L. Wu, IntechOpen, 2024, str. 1-33. https://urn.nsk.hr/urn:nbn:hr:184:831438

Vujičić, Božidar, Koraljka Benko, Ana Petretić, Nenad Nemarnik, Matko Spicijarić, Dean Markić, Matej Bura, Fabio Kadum, Sanjin Rački i Alen Ružić. "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease." U Updates on Renal Replacement Therapy, ur. Henry H.L. Wu, 1-33. IntechOpen, 2024. https://urn.nsk.hr/urn:nbn:hr:184:831438

Vujičić, B., et al. (2024) 'Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease' u H.L. Wu, H. (ur.) Updates on Renal Replacement Therapy IntechOpen, str. 1-33. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:184:831438 (Datum pristupa: 16.11.2024.)

Vujičić B, Benko K, Petretić A, Nemarnik N, Spicijarić M, Markić D, i sur.. Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease. U: H. H.L. Wu, ur. Updates on Renal Replacement Therapy. IntechOpen; 2024. Str. 1-33. [pristupljeno 16.11.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:831438

B. Vujičić, et al., "Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease", Updates on Renal Replacement Therapy, H. H.L. Wu, Ur. IntechOpen, 2024, str. 1-33. [Online] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:831438

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:831438
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Advanced Treatment of Refractory Congestive Heart Failure by Peritoneal Ultrafiltration with Icodextrin in Patients without End-Stage Renal Disease
AutorBožidar Vujičić
AutorKoraljka Benko
AutorAna Petretić
AutorNenad Nemarnik
AutorMatko Spicijarić
AutorDean Markić
AutorMatej Bura
AutorFabio Kadum
AutorSanjin Rački
AutorAlen Ružić
UrednikHenry H.L. Wu
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za urologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Urologija
Sažetak (hrvatski)
In patients with Congestive Heart Failure (CHF), neurohormonal activation leads to fluid overload that can be treated with high doses of furosemide unless diuretic resistance and hyponatremia develop. End-stage CHF, including patients with normal or slightly deteriorated kidney function, can resist medical treatment. In some cases of refractory CHF, ultrafiltration (UF) is required. To manage a refractory CHF population, extracorporeal UF is commonly used as an emergency treatment, but peritoneal UF should be considered a follow-up therapy option. This method offers potential advantages over extracorporeal therapies, including better preservation of residual renal function, tighter control of sodium balance, less neurohumoral activation, and the possibility of daily treatment in the home environment. Using glucose as an osmotic agent leads to the deterioration of the peritoneal membrane. The UF properties of icodextrin depend on the dwell time, whereby the maximum effect of icodextrin concerning glucose is achieved at a prolonged dwell time. Icodextrin may offer improved peritoneal membrane biocompatibility compared with conventional glucose-based dialysates by decreasing glucose exposure, iso-osmolarity, and reduced carbonyl stress. The proper anesthesia technique and surgical approach for peritoneal dialysis (PD) catheter placement in CHF patients must be based on the patient’s characteristics, available equipment, and surgeon’s experience. An open procedure using a transversus abdominis plane block for PD catheter placement in patients with CHF is strongly recommended.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Poglavlje u knjizi
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov knjigeUpdates on Renal Replacement Therapy
Brojčani podacistr. 1-33
ISBN978-1-83769-175-3 (online)
ISBN978-1-83769-174-6 (print)
DOIhttps://doi.org/10.5772/intechopen.114022
URN:NBNurn:nbn:hr:184:831438
Datum objave publikacije2024-01-31
URL dokumentahttps://www.intechopen.com/chapters/88870
Vrsta resursaTekst
IzdavačIntechOpen
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2024-08-16 06:46:47